Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 5 2019 | MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM Practice News Industry Read More Feb 26 2019 | BRILINTA’s Phase III THEMIS Trial met Primary Endopoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes Practice News Industry Read More Feb 19 2019 | Boehringer Ingelheim and Eli Lilly and Company Announce Top-line Results for CAROLINA Study Practice News Industry Read More Feb 6 2019 | New Development in Akcea’s hATTR Compass Program Practice News Industry Read More Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Next page Next › Last page Last »
Mar 5 2019 | MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM Practice News Industry Read More
Feb 26 2019 | BRILINTA’s Phase III THEMIS Trial met Primary Endopoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes Practice News Industry Read More
Feb 19 2019 | Boehringer Ingelheim and Eli Lilly and Company Announce Top-line Results for CAROLINA Study Practice News Industry Read More
Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More
